| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 82952-64-5 | 葡醛酸三甲曲沙; 葡糖醛酸三甲曲沙; 5-甲基-6-[[(3,4,5-三甲氧基苯基)氨基]甲基]喹唑啉-2,4-二胺D-葡糖醛酸鹽 | Trimetrexate glucuronate; 5-Methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]quinazoline-2,4-diamine D-glucuronate |  | C19H23N5O3.C6H10O7 | 詳情 | 供應(yīng)商 |
| 131865-94-6 | Adenosine,2-[2-(4-methylphenyl)ethoxy]-; 2-[2-(4-Methylphenyl)ethoxy]adenosine; WRC 0090 |  | C19H23N5O5 | 詳情 | 供應(yīng)商 | |
| 165905-08-8 | Acetic acid,2-[4-amino-3-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-; Aceticacid, [4-amino-3-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-(9CI); BW-A 215 |  | C19H23N5O5 | 詳情 | 供應(yīng)商 | |
| 29193-86-0 | Adenosine,N-(1-methylethyl)-N-phenyl- (9CI); Adenosine,N-isopropyl-N-phenyl- (8CI) |  | C19H23N5O4 | 詳情 | 供應(yīng)商 | |
| 6374-02-3 | Ethanol,2-[butyl[4-[2-(2,4-dinitrophenyl)diazenyl]-3-methylphenyl]amino]-; C.I.Disperse Violet 13 (7CI,8CI); Ethanol, 2-[butyl[4-[(2,4-dinitrophenyl)azo]-3-methylphenyl]amino]-(9CI); C.I. 11195; Celliton Violet R; Cilla Violet R; Disperse Violet 13 |  | C19H23N5O5 | 詳情 | 供應(yīng)商 | |
| 169318-06-3 | L-Glutamic acid,N-[4-[3-(2,4-diamino-5-pyrimidinyl)propyl]benzoyl]-; LY 316373 |  | C19H23N5O5 | 詳情 | 供應(yīng)商 | |
| 186453-65-6 | Hydrazinecarbothioamide,2-[[4-(diethylamino)phenyl]methylene]-N-[(4-nitrophenyl)methyl]-; Hydrazinecarbothioamide, 2-((4-(diethylamino)phenyl)methylene)-N-((4-n itrophenyl)methyl)- |  | C19H23N5O2S | 詳情 | 供應(yīng)商 | |
| 155271-92-4 | 1H-Purine-2,6-dione,8-[2-[4-(dimethylamino)phenyl]ethenyl]-1,3-diethyl-3,7-dihydro-, (E)- (9CI) |  | C19H23N5O2 | 詳情 | 供應(yīng)商 | |
| 24637-24-9 | 1-Piperazineaceticacid, 4-(2-phenylethyl)-, 2-[(5-nitro-2-furanyl)methylene]hydrazide; 1-Piperazineaceticacid, 4-(2-phenylethyl)-, [(5-nitro-2-furanyl)methylene]hydrazide (9CI); 1-Piperazineacetic acid, 4-phenethyl-, (5-nitrofurfurylidene)hydrazide (8CI) |  | C19H23N5O4 | 詳情 | 供應(yīng)商 | |
| 95847-70-4 | 1,2-Benzisothiazol-3(2H)-one,2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, 1,1-dioxide; Ipsapirone |  | C19H23N5O3S | 詳情 | 供應(yīng)商 | |
| 52128-35-5 | 2,4-Quinazolinediamine,5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-; 2,4-Diamino-5-methyl-6-[(3',4',5'-trimethoxyanilino)methyl]quinazoline; CI 898; JB 11; NSC 249008; NSC 352122; TMQ; Trimetrexate |  | C19H23N5O3 | 詳情 | 供應(yīng)商 | |
| 73090-70-7 | 2,4-Pyrimidinediamine,5-[[3,5-diethoxy-4-(1H-pyrrol-1-yl)phenyl]methyl]-; Epiroprim; Ro 11-8958 |  | C19H23N5O2 | 詳情 | 供應(yīng)商 | |
| 73963-46-9 | 2(1H)-Quinolinone,6-[3-(1-cyclohexyl-1H-tetrazol-5-yl)propoxy]-; 6-[3-(1-Cyclohexyltetrazol-5-yl)propoxy]carbostyril |  | C19H23N5O2 | 詳情 | 供應(yīng)商 | |
| 158020-82-7 | 4H-Pyrazolo[3,4-d]pyrimidin-4-one,1-cyclopentyl-6-(3-ethoxy-4-pyridinyl)-3-ethyl-1,5-dihydro-; 4H-Pyrazolo[3,4-d]pyrimidin-4-one,1-cyclopentyl-6-(3-ethoxy-4-pyridinyl)-3-ethyl-1,7-dihydro- (9CI); Win 65579 |  | C19H23N5O2 | 詳情 | 供應(yīng)商 | |
| 107698-71-5 | 9H-Imidazo[1,2-a]purin-9-one,5-acetyl-6,7-bis(acetyloxy)-3-[4-(acetyloxy)butyl]-3,5,6,7-tetrahydro-; 9H-Imidazo[1,2-a]purin-9-one, 5-acetyl-6,7-bis(acetyloxy)-3-[4-(acetyloxy)butyl]-3,5,6,7-tetrahydro- |  | C19H23N5O8 | 詳情 | 供應(yīng)商 | |
| 38594-96-6 | N6-(1-苯基-2-丙醇)腺苷 | (-)-N6-(2-PHENYLISOPROPYL)-ADENOSINE; (-)-N6-(2-PHENYLISOPROPYL)-ADENOSINE; N6-[L-2-PHENYL-ISOPROPYL]ADENOSINE; [R]-PIA; [R]-N6-[1-METHYL-2-PHENYLETHYL]-ADENOSINE; R-(-)-N6-(2-PHENYL-ISOPROPYL)ADENOSINE; (r)-adenosin; l-n(sup6)-phenylisopropyladenosine; l-phenylisopropyladenosine |  | C19H23N5O4 | 詳情 | 供應(yīng)商 |
| 38594-97-7 | S(+)-N6-(2-PHENYLISOPROPYL)ADENOSINE (S( +)-PIA); S(+)-N6-(2-PHENYLISOPROPYL)ADENOSINE (S( +)-PIA); (l)n6-phenylisopropyladenosine; (+)-N(sup 6)-(S-phenylisopropyl)adenosine; (S)-N6-(1-Methyl-2-phenylethyl)adenosine, (S)-PIA, N6-(D-2-Phenylisopropyl)adenosine; (S)-(2-Phenylisopropyl)adenosine; (S)-N-(1-Methyl-2-phenylethyl)adenosine; (S)-N6-(Phenylisopropyl)adenosine; (S)-N6-Phenyl-2-propyladenosine |  | C19H23N5O4 | 詳情 | 供應(yīng)商 | |